Randomized, Double-blind, Placebo-controlled, Dose Escalated Tolerance and Pharmacokinetic / Pharmacodynamic Studies of SY-008 Capsules Administered by Chinese Healthy Volunteers

Trial Profile

Randomized, Double-blind, Placebo-controlled, Dose Escalated Tolerance and Pharmacokinetic / Pharmacodynamic Studies of SY-008 Capsules Administered by Chinese Healthy Volunteers

Recruiting
Phase of Trial: Phase I

Latest Information Update: 29 Jun 2018

At a glance

  • Drugs SY 008 (Primary)
  • Indications Diabetes mellitus
  • Focus Adverse reactions
  • Sponsors Yabao Pharmaceutical Group
  • Most Recent Events

    • 19 Jun 2018 Planned End Date changed from 30 Sep 2018 to 30 Nov 2018.
    • 19 Jun 2018 Planned primary completion date changed from 23 Aug 2018 to 31 Oct 2018.
    • 14 Mar 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top